Press Releases

Press Releases

Vanda Pharmaceuticals Inc. today announced that it has named Tom Gibbs as Senior Vice President, Chief Commercial Officer of the company.  Mr. Gibbs has 20 years of experience in the pharmaceutical industry, including several senior-level leadership roles in global sales and marketing. "We are very pleased to welcome Tom to…

Tuesday, Apr 21, 2015
Press Releases

Pharma Major Lupin Limited announced today that its Canadian subsidiary, Lupin Pharma Canada Limited (collectively Lupin) has launched its first Brand product Zaxine® under a strategic licensing agreement with the North Carolina based GI specialty company Salix Pharmaceuticals Inc. The agreement grants Lupin exclusive rights to promote, distribute and market…

Press Releases

DelMar Pharmaceuticals, Inc., a biopharmaceutical company focused on developing and commercializing proven cancer therapies in new orphan drug indications, today announced updated clinical data on the identification of maximum tolerated dose (MTD) from its Phase I/II study of its lead product candidate VAL-083 (dianhydrogalactitol) in patients with refractory glioblastoma multiforme…

Press Releases

Fred’s, Inc. today announced that it has completed the previously reported $66 million acquisition of Reeves-Sain Drug Store, Inc., a private specialty and retail pharmacy company, including its EntrustRx specialty pharmacy operation. EntrustRx, which is licensed in all 50 states, has a strong regional presence in the Southeast, serviced from…

Press Releases

Provectus Biopharmaceuticals, Inc., a clinical-stage oncology and dermatology biopharmaceutical company (“Provectus” or the “Company”), announced today that it has received from the US Patent and Trademark Office a Notice of Allowance for a joint patent application made with Pfizer, Inc. The patent will protect use of PV-10 in combination with…

Press Releases

Bionomics Limited, a biopharmaceutical company focused on the discovery and development of innovative therapeutics for the treatment of cancer and diseases of the central nervous system, today announced the initiation of a Phase II clinical study of BNC210, the Company's drug candidate in development for the treatment of anxiety and…

Press Releases

Amerigen Pharmaceuticals Limited announced that the U.S. Food and Drug Administration (FDA) has granted tentative approval to the Company's Abbreviated New Drug Application (ANDA) for a generic version of Bystolic® (Nebivolol HCl 2.5, 5, 10 and 20mg instant release tablets). Based upon available information, Amerigen believes that it is a…

Press Releases

Actavis plc today announced that it intends to release first quarter 2015 financial results on Monday, May 11, 2015, prior to the open of the U.S. financial markets.  The Company will host a conference call and webcast at 8:00 a.m. Eastern Time on Monday, May 11, 2015 to discuss its…

Press Releases

Vanda Pharmaceuticals Inc., a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders, today announced it will release results for the first quarter of 2015 on Wednesday, May 6, 2015, after the market closes. The Company will host a conference call…

Press Releases

Center for iPS Cell Research Application (CiRA) of Kyoto University and Takeda Pharmaceutical Company Limited (Takeda) announced today that they will work together to develop clinical applications of induced pluripotent stem cells in areas such as heart failure, diabetes mellitus, neurological disorders and cancer immunotherapy. The "Takeda-CiRA Joint Program for…